Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Reputation and power organizational image and pharmaceutical regulation at the FDA [[electronic resource] /] / Daniel Carpenter
| Reputation and power organizational image and pharmaceutical regulation at the FDA [[electronic resource] /] / Daniel Carpenter |
| Autore | Carpenter Daniel P. <1967-> |
| Edizione | [Course Book] |
| Pubbl/distr/stampa | Princeton, : Princeton University Press, c2010 |
| Descrizione fisica | 1 online resource (825 p.) |
| Disciplina | 362.17/82 |
| Collana | Princeton studies in American politics |
| Soggetto topico |
Pharmaceutical policy - United States
Drugs - Research - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-282-63948-X
9786612639487 1-4008-3511-9 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; CONTENTS; LIST OF ILLUSTRATIONS; LIST OF TABLES; ACKNOWLEDGMENTS; LIST OF ABBREVIATIONS AND ACRONYMS; INTRODUCTION: The Gatekeeper; CHAPTER ONE: Reputation and Regulatory Power; PART ONE: ORGANIZATIONAL EMPOWERMENT AND CHALLENGE; CHAPTER TWO: Reputation and Gatekeeping Authority: The Federal Food, Drug and Cosmetic Act of 1938 and Its Aftermath; CHAPTER THREE: The Ambiguous Emergence of American Pharmaceutical Regulation, 1944-1961; CHAPTER FOUR: Reputation and Power Crystallized: Thalidomide, Frances Kelsey, and Phased Experiment, 1961-1966
CHAPTER FIVE: Reputation and Power Institutionalized: Scientific Networks, Congressional Hearings, and Judicial Affirmation, 1963-1986CHAPTER SIX: Reputation and Power Contested: Emboldened Audiences in Cancer and AIDS, 1977-1992; PART TWO: PHARMACEUTICAL REGULATION AND ITS AUDIENCES; CHAPTER SEVEN: Reputation and the Organizational Politics of New Drug Review; CHAPTER EIGHT: The Governance of Research and Development: Gatekeeping Power, Conceptual Guidance, and Regulation by Satellite; CHAPTER NINE: The Other Side of the Gate: Reputation, Power, and Post-Market Regulation CHAPTER TEN: The Détente of Firm and RegulatorCHAPTER ELEVEN: American Pharmaceutical Regulation in International Context: Audiences, Comparisons, and Dependencies; CHAPTER TWELVE: Conclusion: A Reputation in Relief; PRIMARY SOURCES AND ARCHIVAL COLLECTIONS; INDEX |
| Record Nr. | UNINA-9910459384503321 |
Carpenter Daniel P. <1967->
|
||
| Princeton, : Princeton University Press, c2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Reputation and power organizational image and pharmaceutical regulation at the FDA [[electronic resource] /] / Daniel Carpenter
| Reputation and power organizational image and pharmaceutical regulation at the FDA [[electronic resource] /] / Daniel Carpenter |
| Autore | Carpenter Daniel P. <1967-> |
| Edizione | [Course Book] |
| Pubbl/distr/stampa | Princeton, : Princeton University Press, c2010 |
| Descrizione fisica | 1 online resource (825 p.) |
| Disciplina | 362.17/82 |
| Collana | Princeton studies in American politics |
| Soggetto topico |
Pharmaceutical policy - United States
Drugs - Research - United States |
| ISBN |
1-282-63948-X
9786612639487 1-4008-3511-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; CONTENTS; LIST OF ILLUSTRATIONS; LIST OF TABLES; ACKNOWLEDGMENTS; LIST OF ABBREVIATIONS AND ACRONYMS; INTRODUCTION: The Gatekeeper; CHAPTER ONE: Reputation and Regulatory Power; PART ONE: ORGANIZATIONAL EMPOWERMENT AND CHALLENGE; CHAPTER TWO: Reputation and Gatekeeping Authority: The Federal Food, Drug and Cosmetic Act of 1938 and Its Aftermath; CHAPTER THREE: The Ambiguous Emergence of American Pharmaceutical Regulation, 1944-1961; CHAPTER FOUR: Reputation and Power Crystallized: Thalidomide, Frances Kelsey, and Phased Experiment, 1961-1966
CHAPTER FIVE: Reputation and Power Institutionalized: Scientific Networks, Congressional Hearings, and Judicial Affirmation, 1963-1986CHAPTER SIX: Reputation and Power Contested: Emboldened Audiences in Cancer and AIDS, 1977-1992; PART TWO: PHARMACEUTICAL REGULATION AND ITS AUDIENCES; CHAPTER SEVEN: Reputation and the Organizational Politics of New Drug Review; CHAPTER EIGHT: The Governance of Research and Development: Gatekeeping Power, Conceptual Guidance, and Regulation by Satellite; CHAPTER NINE: The Other Side of the Gate: Reputation, Power, and Post-Market Regulation CHAPTER TEN: The Détente of Firm and RegulatorCHAPTER ELEVEN: American Pharmaceutical Regulation in International Context: Audiences, Comparisons, and Dependencies; CHAPTER TWELVE: Conclusion: A Reputation in Relief; PRIMARY SOURCES AND ARCHIVAL COLLECTIONS; INDEX |
| Record Nr. | UNINA-9910784924303321 |
|
Carpenter Daniel P. <1967->
|
||
| Princeton, : Princeton University Press, c2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Reputation and power organizational image and pharmaceutical regulation at the FDA [[electronic resource] /] / Daniel Carpenter
| Reputation and power organizational image and pharmaceutical regulation at the FDA [[electronic resource] /] / Daniel Carpenter |
| Autore | Carpenter Daniel P. <1967-> |
| Edizione | [Course Book] |
| Pubbl/distr/stampa | Princeton, : Princeton University Press, c2010 |
| Descrizione fisica | 1 online resource (825 p.) |
| Disciplina | 362.17/82 |
| Collana | Princeton studies in American politics |
| Soggetto topico |
Pharmaceutical policy - United States
Drugs - Research - United States |
| ISBN |
1-282-63948-X
9786612639487 1-4008-3511-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; CONTENTS; LIST OF ILLUSTRATIONS; LIST OF TABLES; ACKNOWLEDGMENTS; LIST OF ABBREVIATIONS AND ACRONYMS; INTRODUCTION: The Gatekeeper; CHAPTER ONE: Reputation and Regulatory Power; PART ONE: ORGANIZATIONAL EMPOWERMENT AND CHALLENGE; CHAPTER TWO: Reputation and Gatekeeping Authority: The Federal Food, Drug and Cosmetic Act of 1938 and Its Aftermath; CHAPTER THREE: The Ambiguous Emergence of American Pharmaceutical Regulation, 1944-1961; CHAPTER FOUR: Reputation and Power Crystallized: Thalidomide, Frances Kelsey, and Phased Experiment, 1961-1966
CHAPTER FIVE: Reputation and Power Institutionalized: Scientific Networks, Congressional Hearings, and Judicial Affirmation, 1963-1986CHAPTER SIX: Reputation and Power Contested: Emboldened Audiences in Cancer and AIDS, 1977-1992; PART TWO: PHARMACEUTICAL REGULATION AND ITS AUDIENCES; CHAPTER SEVEN: Reputation and the Organizational Politics of New Drug Review; CHAPTER EIGHT: The Governance of Research and Development: Gatekeeping Power, Conceptual Guidance, and Regulation by Satellite; CHAPTER NINE: The Other Side of the Gate: Reputation, Power, and Post-Market Regulation CHAPTER TEN: The Détente of Firm and RegulatorCHAPTER ELEVEN: American Pharmaceutical Regulation in International Context: Audiences, Comparisons, and Dependencies; CHAPTER TWELVE: Conclusion: A Reputation in Relief; PRIMARY SOURCES AND ARCHIVAL COLLECTIONS; INDEX |
| Record Nr. | UNINA-9910813972203321 |
|
Carpenter Daniel P. <1967->
|
||
| Princeton, : Princeton University Press, c2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||